最新研究进展 -MedSci.cn 相关研究进展 -MedSci.cn

筛选条件 共查询到132条结果

排序方式

文献标题

第一作者

所属期刊

影响指数

重置筛选

CDK4/6 inhibition in early-stage breast cancer: how far is it from becoming standard of care?

期刊： LANCET ONCOLOGY, 2021; 22 (2)

Indications for individual internal mammary node irradiation

期刊： LANCET ONCOLOGY, 2021; 22 (2)

Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial

期刊： LANCET ONCOLOGY, 2021; 22 (8)

Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial

期刊： LANCET ONCOLOGY, 2021; 22 (4)

Re-irradiation versus surgery for locally recurrent nasopharyngeal carcinoma reply

期刊： LANCET ONCOLOGY, 2021; 22 (6)

Re-irradiation versus surgery for locally recurrent nasopharyngeal carcinoma

期刊： LANCET ONCOLOGY, 2021; 22 (6)

Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial

期刊： LANCET ONCOLOGY, 2021; 22 (8)

Second-line FOLFOX chemotherapy for advanced biliary tract cancer

期刊： LANCET ONCOLOGY, 2021; 22 (7)

Twice-daily chemoradio-therapy in limited-stage small-cell lung cancer

期刊： LANCET ONCOLOGY, 2021; 22 (6)

Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma

期刊： LANCET ONCOLOGY, 2021; 22 (8)

Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma

期刊： LANCET ONCOLOGY, 2021; 22 (8)

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study

期刊： LANCET ONCOLOGY, 2021; 22 (7)

Secondary cytoreduction for relapsed ovarian cancer reply

期刊： LANCET ONCOLOGY, 2021; 22 (6)

Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer

期刊： LANCET ONCOLOGY, 2021; 22 (8)

Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial

期刊： LANCET ONCOLOGY, 2021; 22 (5)

内科

外科

其它科室

热点

按科室浏览

科研工具

写作工具

其他工具

平台业务解决方案

真实世界研究解决方案

数字化学术传播解决方案

其它

科室

工具

服务